SMALL CAP MOVERS: Poolbeg Pharma

SMALL CAP IDEAS: The small UK-listed drug developers set to benefit from the looming RSV vaccines’ approval

Poolbeg Pharma soars on new US patents; Doorstep lender Morses Club tumbles as it delays results

MIDAS SHARE TIPS: Poolbeg Pharma’s flu treatment could prove an exciting opportunity for the adventurous investor’s portfolio

Poolbeg Pharma
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.